HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-Operative Management of Paget-Schroetter Syndrome: A Single-Center Experience.

AbstractOBJECTIVE:
The preponderance of existing literature for the treatment of Paget-Schroetter syndrome (PSS) advocates clot lysis followed by thoracic outlet decompression (TOD). We postulate that long-term anticoagulation has equal outcomes to more invasive and costly surgical intervention, and review our experience with non-operative management of PSS.
METHODS:
A retrospective review was conducted, examining patients between 1994-2014. Forty patients were identified with PSS, and 27 of these patients had sufficient follow-up for this analysis. Charts were reviewed for details of clinical presentation, disease course, interventions, duration of oral anticoagulation, ultrasound reports, and symptoms at long-term follow-up.
RESULTS:
With a mean follow-up of 54.3 months, 23/27 patients (85%) were asymptomatic after non-operative therapy. In this cohort, 16/27 patients (59%) underwent catheter-directed thrombolysis. Average treatment course with oral anticoagulation was 8.6 months. Four patients (15%) remained symptomatic at follow-up. Two patients (7%) underwent thoracic outlet decompression at another institution, with good results. At least partial recanalization of vessels was documented in 25/27 patients (93%), although recanalization did not correlate with symptoms at long-term follow-up.
CONCLUSIONS:
Based upon equivalent functional results, non-operative management appears to offer similar outcomes for some patients with PSS. We propose a patient-tailored approach to the treatment of PSS, in which patients presenting acutely undergo catheter-directed thrombolysis, followed by a 6-12 month course of oral anticoagulation. Persistent symptoms, recurrent disease, lengthy duration of symptoms prior to diagnosis, and identifiable structural abnormalities may be factors predictive of poor outcomes after non-operative intervention.
AuthorsSelena G Goss, Sean D Alcantara, George J Todd, John C Lantis 2nd
JournalThe Journal of invasive cardiology (J Invasive Cardiol) Vol. 27 Issue 9 Pg. 423-8 (Sep 2015) ISSN: 1557-2501 [Electronic] United States
PMID26332877 (Publication Type: Journal Article)
Chemical References
  • Anticoagulants
Topics
  • Administration, Oral
  • Adult
  • Anticoagulants (administration & dosage, adverse effects)
  • Conservative Treatment (adverse effects, economics, methods, statistics & numerical data)
  • Female
  • Humans
  • Long Term Adverse Effects (diagnosis, etiology, physiopathology)
  • Male
  • Outcome and Process Assessment, Health Care
  • Patient Selection
  • Retrospective Studies
  • Risk Adjustment
  • Symptom Assessment (methods, statistics & numerical data)
  • Thrombolytic Therapy (adverse effects, economics, methods)
  • United States
  • Upper Extremity Deep Vein Thrombosis (diagnosis, etiology, physiopathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: